AUA 2014 General News Coverage
At its annual meeting, the American Urological Association provided details of its first guidelines for the medical management of urolithiasis.
The risk of cancer-specific death at 1 year was 48% and 23% for patients whose disease recurred at 3 months and 3 years, respectively.
Researchers compared transurethral resection of the prostate with prostate artery embolization in a randomized trial.
The proportion of patients undergoing the procedure has stayed at 6%-7% annually.
Larger tumor size, male sex, and higher nephrometry score indicate a greater likelihood that a renal mass is malignant, researchers report.
Their risk of death is 40% lower than that of patients who are not obese, study shows.
Intrauterine insemination success rates decrease by 20% with each 10-year increment in men's age.
Ejaculatory function worsens, however, in men taking 5 alpha-reductase inhibitors.
The cure rate was 82.5% at 13 years after surgery, investigators report.
Even multiple treatments have a negligible effect, Canadian researchers concluded.
The DISSRM score may be an easy-to-calculate surrogate for competing risk mortality.
In a study, the re-intervention rate was 11% for patients treated with shock wave lithotripsy versus 0.2% of those who had ureteroscopy.
Open procedures, preoperative dialysis, and higher ASA score were significant predictors of readmission after radical nephrectomy.
Following guidelines from the AUA and NCCN would miss many cases of disease recurrence following surgery, study suggests.
Researchers looked at the effect of insurance coverage expansion in Massachusetts.
Venous thromboembolism is more likely to occur in patients with neurologic comorbidities and increased operative time.
It achieved a stone-free rate of 95% in patients with stones smaller than 2 cm.
Patients of lower socioeconomic status present with larger tumors, higher T stage, positive lymph nodes.
A higher rate of distal ureteral stone clearance was observed with a dual regimen of tamsulosin and prednisone than with either drug alone.
Adjuvant treatment with the medication was associated with higher clearance rates for upper urinary tract stones.
It offers a survival benefit regardless of age, but is used less often in patients aged 70 years and older than in younger patients.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)